Drug intelligence / Profile preview

cefepime + sulbactam

Development stage
Unknown
Lead developer
Venus Remedies
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Cefepime + sulbactam is a fixed-dose combination antibiotic consisting of cefepime, a fourth-generation cephalosporin, and sulbactam, a beta-lactamase inhibitor. Cefepime exerts its bactericidal activity by binding to and inhibiting penicillin-binding proteins (PBPs), which are essential for the synthesis of the bacterial cell wall. Sulbactam acts as a suicide inhibitor of certain beta-lactamases (primarily Class A and some Class C enzymes), thereby protecting cefepime from enzymatic degradation and extending its spectrum of activity against resistant Gram-negative pathogens, including *Acinetobacter baumannii* and *Pseudomonas aeruginosa*. This combination is typically administered parenterally for the treatment of serious systemic infections, particularly those suspected to be caused by multi-drug resistant (MDR) bacteria producing beta-lactamases.

Brand names
SupimeCefepime-SCefepime Sulbactam
Other names
cefepime/sulbactamsulbactam + cefepime
02

Targets

PBP (Penicillin-binding protein family)Neuraminidase

Beyond the preview

Go deeper on cefepime + sulbactam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefepime + sulbactam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call